Akari Therapeutics (AKTX) Stock Chart & Stock Price History $1.39 +0.02 (+1.68%) Closing price 05/7/2025 03:59 PM EasternExtended Trading$1.35 -0.05 (-3.37%) As of 06:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Akari Therapeutics Stock Price Performance 5 Day Performance+0.94%1 Month Performance+21.13%3 Month Performance+8.40%6 Month Performance-43.14%Year-To-Date Performance+14.18%1 Year Performance-3.93% Receive AKTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address AKTX Stock Chart for Thursday, May, 8, 2025 AKTX Chart by TradingView Akari Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/07/2025$1.37$1.39+1.68%$1.46$1.3522,567 shs$37.04 million05/06/2025$1.41$1.37-2.84%$1.45$1.3424,865 shs$36.43 million05/05/2025$1.38$1.41+2.17%$1.47$1.3675,497 shs$37.50 million05/02/2025$1.40$1.38-1.43%$1.39$1.288,068 shs$36.70 million05/01/2025$1.44$1.40-2.78%$1.43$1.382,476 shs$37.23 million04/30/2025$1.37$1.44+5.11%$1.48$1.3227,826 shs$38.29 million04/29/2025$1.40$1.37-2.14%$1.40$1.306,729 shs$36.43 million04/28/2025$1.43$1.40-2.10%$1.45$1.406,080 shs$37.23 million04/25/2025$1.46$1.43-2.05%$1.48$1.432,521 shs$38.03 million04/24/2025$1.45$1.46+0.48%$1.49$1.4063,587 shs$38.83 million Get the Latest News and Ratings for AKTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/23/2025$1.36$1.45+6.84%$1.45$1.2431,096 shs$38.64 million04/22/2025$1.28$1.36+6.25%$1.58$1.18202,127 shs$36.17 million04/21/2025$1.20$1.28+6.31%$1.29$1.0391,273 shs$34.04 million04/18/2025$1.20$1.20$1.28$1.1017,294 shs$32.02 million04/17/2025$1.10$1.20+9.45%$1.28$1.1017,294 shs$32.02 million04/16/2025$1.20$1.10-8.24%$1.19$1.1010,023 shs$29.25 million04/15/2025$1.11$1.20+7.71%$1.27$1.123,403 shs$31.88 million04/14/2025$1.07$1.11+4.02%$1.12$1.094,993 shs$29.60 million04/11/2025$1.11$1.07-3.60%$1.15$1.0711,105 shs$28.46 million04/10/2025$1.19$1.11-6.71%$1.18$1.0616,913 shs$29.52 million04/09/2025$1.15$1.19+3.47%$1.21$1.0836,719 shs$31.64 million04/09/2025$1.15$1.19+3.47%$1.21$1.0836,719 shs$31.64 million04/08/2025$1.10$1.15+4.55%$1.27$1.1329,022 shs$30.58 million04/08/2025$1.10$1.15+4.55%$1.27$1.1329,022 shs$30.58 million04/07/2025$1.09$1.10+0.92%$1.16$1.0119,020 shs$29.25 million Related Companies Puma Biotechnology Stock Chart Cybin Stock Chart Aclaris Therapeutics Stock Chart Eupraxia Pharmaceuticals Stock Chart Neoleukin Therapeutics Stock Chart ADC Therapeutics Stock Chart Fate Therapeutics Stock Chart Nkarta Stock Chart Organigram Stock Chart Greenwich LifeSciences Stock Chart Receive AKTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AKTX) was last updated on 5/8/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be la...Porter & Company | Sponsored270x more lucrative than NVIDIA???270x more lucrative than NVIDIA??? If you've missed out on NVIDIA's recent 1,600% run... Don't worry. ...Behind the Markets | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredVanishing BenefitsWhat would you do if your next Social Security check simply never arrived? If you called and the line was d...Investors Alley | SponsoredSilver’s 332% Surge?Silver has quietly become one of the most promising investments of this cycle. Russia is now stockpiling silve...Lear Capital | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akari Therapeutics, Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Akari Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AKTX Stock Free AKTX Stock Alerts